Tagrix 80mg vs. Other EGFR Inhibitors: A Comparison
Tagrix 80mg contains the main active ingredient Osimertinib mesylate, available in tablet form, which is indicated for use mainly in the targeted treatment of non-small cell lung cancer. The drug Tagrix 80mg (Osimertinib) Beacon has been tested and used in many countries, including Vietnam